$PRLB

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.

Original reporting
Published Aug 14, 2026, 8:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 6:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Proto Labs (PRLB) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PRLBBullishHigh
01

Why it matters

The key tradable items are the raised full-year revenue growth outlook, Q3 revenue and non-GAAP EPS guidance ranges, and margin expansion alongside a stated regional profitability risk in Europe.

02

Market read

A guidance raise with explicit Q3 and FY ranges plus margin expansion is likely to drive near-term repricing, tempered by Europe profitability execution risk.

03

What to watch

Network fulfillment revenue was described as flat as customers shifted toward factory services, which could indicate mix shifts that may not fully sustain margin gains.

Relevance 9/10Novelty 9/10Timing: post-earnings call, with Q3 and FY2026 guidance ranges disclosed

Background

This is a transcript-style earnings call summary for Proto Labs’ Q2 fiscal 2026 results, including detailed segment performance, margin metrics, and forward guidance.

Company-level read

Ticker impact

$PRLBBullishMedium confidence
Context

Proto Labs reported Q2 record revenue of $149.3M, raised FY2026 growth guidance to 8% to 10%, and guided Q3 non-GAAP EPS to $0.56 to $0.64.

Expected impact

Bias toward upside on earnings/guidance interpretation, with potential volatility if investors focus on Europe profitability progress.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: record revenue, margin expansion, and explicit Q3 and FY guidance ranges, plus a management caveat that Europe profitability is still a work in process.

Market effects

Signals improving demand and pricing strength in CNC machining and injection molding, with aerospace and defense remaining a key growth driver.

Highlights Europe as a swing factor, where profitability transformation is ongoing despite revenue growth.

Reinforces broader manufacturing/industrial AI and “physical AI” automation narrative, potentially affecting sentiment toward additive and prototyping supply chains.

Counterpoint

Investors may discount the guidance raise if Europe profitability progress lags, especially given management’s explicit “work in process” comment.

Key entities

  • Proto Labs, Inc.

    Reported Q2 2026 record revenue and expanded margins, raised FY2026 guidance, and provided Q3 revenue and non-GAAP EPS guidance.

  • Suresh Krishna

    CEO who attributed performance to customer engagement, aerospace and defense demand, and “physical AI,” while noting Europe profitability is still in progress.

  • Dan Schumacher

    CFO who discussed network fulfillment mix and provided financial guidance and margin commentary.

Related articles

$PRLBLow

Protolabs Names Sam Ramahi COO to Lead Global Manufacturing Operations

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.

$PRLBMedAI 8/10

Proto Labs: Q2 Earnings Snapshot

Proto Labs Inc. (PRLB) reported Q2 profit of $9.2 million, or 37 cents per share. Adjusted earnings were 60 cents per share, and revenue was $149.3 million. For the quarter ending September, the company forecast 56 to 64 cents per share. For fiscal Q3, it expects revenue of $145 million to $153 million.